TickerGuard
Buy Day today: Neutral (61) Mixed market breadth · no major macro event
TWST

Twist Bioscience Corp

Healthcare · Diagnostics & Research

167.00$ +7.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement TWST
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
415.2% 223.1% 126.6% 87.2% 68.2% 60.9% 58.6% 63.4% 57.4% 49.3%
-315.2% -123.1% -26.6% 12.8% 31.8% 39.1% 41.4% 36.6% 42.6% 50.7%
803.4% 178.0% 80.0% 65.6% 47.7% 52.2% 59.1% 43.6% 29.0% 21.3%
796.6% 241.1% 167.3% 144.9% 113.3% 100.8% 103.4% 76.2% 69.8% 63.7%
1,608.8% 420.1% 250.9% 212.9% 187.3% 154.5% 163.7% 125.2% 113.2% 86.9%
-1,924.0% -543.2% -277.5% -200.1% -155.5% -115.4% -122.3% -88.6% -70.6% -36.2%
32.9% 8.4% 5.2% 2.4% 0.9% 0.3% 0.0% 0.0% 0.0%
-1,943.1% -548.2% -279.2% -197.4% -154.9% -116.4% -112.1% -83.0% -66.5% -20.4%
36.1% 2.6% 1.0% 0.5% 0.4% -1.5% -5.1% 0.5% 0.2% 0.2%
-1,943.1% -550.8% -280.2% -198.0% -155.3% -114.9% -107.0% -83.5% -66.7% -20.6%
-1,723.8% -493.2% -251.5% -183.5% -146.6% -108.7% -121.4% -71.1% -56.5% -13.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?